Eosinophils depletion therapy for severe asthma management following favorable response to mepolizumab.
第一作者:
Osamu,Matsuno
第一单位:
Department of Medicine for Allergic Disease, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583-8588, Japan.
作者:
关键词
ACT, Asthma control testBT, bronchial thermoplastyBenralizumabCT, computed tomographyEosinophilFEV1, expiratory volume in 1 secondFVC, forced vital capacityFeNO, fraction of exhaled nitric oxideICS, inhaled corticosteroidsLABA, long-acting beta-agonistLAMA, long-acting muscarinic antagonistLTRA, leukotriene antagonistMepolizumabSevere asthma
DOI
10.1016/j.rmcr.2019.100899
PMID
31341763
发布时间
2020-09-30
- 浏览0
Respiratory medicine case reports
2019年28卷
100899页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



